Literature DB >> 19130293

Oral potassium iodide for the treatment of sporotrichosis.

Si-Liang Xue1, Li Li.   

Abstract

Potassium Iodide is the antimycotic of choice for the treatment of cutaneous sporotrichosis, because of its efficacy, safety and low cost. We carried out a review of published studies on the benefits and adverse reactions of using SSKI (Saturated Solution Potassium Iodide) as treatment for sporotrichosis, but could not identify any well-designed clinical trails. There is an urgent need to conduct randomized double-blind placebo-controlled trials and critically assess usefulness of SSKI by using a standardize monitoring or an effective self-report system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130293     DOI: 10.1007/s11046-008-9178-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  5 in total

1.  Isolation of Sporothrix schenckii in the soil in Israel in relation to a new case in man.

Authors:  E J Feuerman; I Alteras; D Bashan; N B Lehrer
Journal:  Sabouraudia       Date:  1976-07

2.  Localized lymphatic sporotrichosis after fish-induced injury (Tilapia sp.).

Authors:  V Júnior Haddad; H A Miot; L D Bartoli; A de Chiara Cardoso; R M Pires de Camargo
Journal:  Med Mycol       Date:  2002-08       Impact factor: 4.076

3.  Potassium iodide remains the most effective therapy for cutaneous sporotrichosis.

Authors:  K Sandhu; S Gupta
Journal:  J Dermatolog Treat       Date:  2003-12       Impact factor: 3.359

Review 4.  Identifying and treating mycotic skin infections.

Authors:  Jennifer T Trent; Robert S Kirsner
Journal:  Adv Skin Wound Care       Date:  2003 May-Jun       Impact factor: 2.347

Review 5.  Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literature.

Authors:  Basak Coskun; Yunus Saral; Nusret Akpolat; Arzu Ataseven; Demet Ciçek
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 3.785

  5 in total
  5 in total

1.  Advances in antimicrobial photodynamic inactivation at the nanoscale.

Authors:  Nasim Kashef; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanophotonics       Date:  2017-08-01       Impact factor: 8.449

Review 2.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Sporothrix schenckii COMPLEX:SUSCEPTIBILITIES TO COMBINED ANTIFUNGAL AGENTS AND CHARACTERIZATION OF ENZYMATIC PROFILES.

Authors:  Daniele Carvalho Oliveira; Érico Silva de Loreto; Débora Alves Nunes Mario; Paulo G Markus Lopes; Louise Vignolles Neves; Marta Pires da Rocha; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

4.  Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics.

Authors:  Rosane Orofino-Costa; Priscila Marques de Macedo; Anderson Messias Rodrigues; Andréa Reis Bernardes-Engemann
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

Review 5.  Sporotrichosis: a Comprehensive Review on Recent Drug-Based Therapeutics and Management.

Authors:  Bunty Sharma; Anil Kumar Sharma; Ujjawal Sharma
Journal:  Curr Dermatol Rep       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.